AGTX — Agentix Share Price
Last Trade - 00:00Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Aug | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.04 | 0 | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Agentix Corp. is an early-stage biopharmaceutical company. The Company focuses on the development of a suite of health solutions for patients and consumers, with a balance of generic -based pharmaceutical products with its delivery system, and small molecule pharmaceuticals targeting the G-protein coupled receptors (GPCRs) of the endocannabinoid system (ECS). The Company utilizes a cellular delivery technology, known as a cellular biocomplex, for the health and wellness markets. Its biocomplexes are used in the development and production of pharma-grade products for clinical applications in dermatology, oncology and neurology. It also includes a series of molecules which acts on the endocannabinoid receptors for applications regulating metabolism, as well as additional indications in nephrology and neurology.
Directors
- Last Annual
- August 31st, 2020
- Last Interim
- May 31st, 2021
- Incorporated
- April 18th, 2013
- Public Since
- August 5th, 2015
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 34,874,605
- Address
- 32932 PACIFIC COAST HIGHWAY, #14-254, DANA POINT, 92629
- Web
- https://agentixcorp.com/
- Phone
- +1 3212292014
- Auditors
- Fruci & Associates II, PLLC
Upcoming events for AGTX
Similar to AGTX
AEOLUS PHARMACEUTICALS ORD
Pink Sheets on Nasdaq
ANTIGENICS ORD
Pink Sheets on Nasdaq
ARNO THERAPEUTICS ORD
Pink Sheets on Nasdaq
ARYX THERAPEUTICS ORD
Pink Sheets on Nasdaq
FUTUREWORLD ORD
Pink Sheets on Nasdaq
FAQ
As of Today at 19:57 UTC, shares in Agentix are trading at $1.00. This share price information is delayed by 15 minutes.
Shares in Agentix last closed at $1.00 and the price had moved by -67.32% over the past 365 days. In terms of relative price strength the Agentix share price has underperformed the S&P500 Index by -74.72% over the past year.
There is no consensus recommendation for this security.
Agentix does not currently pay a dividend.
Agentix does not currently pay a dividend.
Agentix does not currently pay a dividend.
To buy shares in Agentix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.00, shares in Agentix had a market capitalisation of $34.87m.
Here are the trading details for Agentix:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: AGTX
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Agentix does not currently have a style classification.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agentix. Over the past six months, its share price has underperformed the S&P500 Index by -33.75%.
As of the last closing price of $1.00, shares in Agentix were trading -71.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Agentix.
Agentix's management team is headed by:
- Rudy Mazzocchi -
- Robert Whalen -
- Michael Winterhalter - TRS
- Rehan Huda -
We do not have data on Agentix's shareholders